About the Event
Join Donald E. Wesson, M.D., MBA, for “Neutralizing the Risk: Managing Acidosis in CKD,” an upcoming Internal Medicine Grand Rounds presentation exploring the impact of metabolic acidosis in chronic kidney disease and current approaches to treatment. Attendees will learn how metabolic acidosis affects multiple organ systems, review evidence-based treatment strategies, and understand the benefits and potential complications associated with approved therapies.
Dr. Wesson is a nationally recognized leader in nephrology, population health, and academic medicine. He is the immediate past president of the Baylor Scott & White Health and Wellness Center and currently serves as a professor of medicine at Dell Medical School and The University of Texas Southwestern Medical Center. An internationally recognized researcher in kidney acidifying mechanisms, he has authored more than 150 scientific publications, numerous books on kidney disease and hypertension, and has helped translate basic science discoveries into clinical advances focused on nutrition and kidney health.
Learning Objectives
By the end of this presentation, the audience participant should be able to:
- 1. Identify multiple organ systems adversely affected by metabolic acidosis in chronic kidney disease (CKD).
- Describe ways by which metabolic acidosis in CKD can be treated.
- Describe benefits and possible complications of the approved ways by which metabolic acidosis might be treated.
For more information, contact Grace Fontes.
Target Audience
- Primary: Department of Internal Medicine faculty, residents and fellows; associate providers
- Secondary: Medical students, Family Medicine faculty and residents
Attributes/Competencies
This activity has been designed to promote some of the following desired physician attributes and competencies:
- ACGME: Patient Care; Medical Knowledge; Practice-Based Learning and Improvement; Professionalism; Systems-Based Practice
- IOM: Provide Patient-Centered Care; Work in Interdisciplinary Teams; Employ Evidence-Based Practice; Apply Quality Improvement
- IECC: Interprofessional Teamwork and Team-based Practice, Interprofessional Communication
Speaker and Planner Disclosure
Dr. Wesson is a consultant for Renibus Therapeutics. All of the relevant financial relationships listed for these individuals have been mitigated.
Planners for this educational activity have no relevant financial relationships(s) with ineligible companies to disclose.
The CME Advisory Committee, reviewers of this educational activity, have no relevant relationship(s) with ineligible companies to disclose.
Accreditation Statement
The University of Texas at Austin Dell Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas at Austin Dell Medical School designates this internet live course for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.